Celltrion – Talk Bio

Actionable Insights Powered by AI

Celltrion Acquires Eli Lilly’s New Jersey Manufacturing Site for $330 Million

1 month ago talkbio0Tagged Acquisition, Biopharmaceutical manufacturing, Biosimilars, Celltrion, Contract agreement, eli lilly, Investments, Jersey site, supply chain, US tariffs

Celltrion; Eli Lilly; New Jersey site; acquisition; biopharmaceutical manufacturing; US tariffs; contract manufacturing; supply chain; biosimilars; investment

Amgen and Celltrion Reach Settlement in Denosumab Patent Litigation, Paving Way for Mid-2025 Biosimilar Launch

9 months ago talkbio0Tagged amgen, Biosimilars, Celltrion, denosumab, launch, Legal patent, Litigation, settlement

Amgen, Celltrion, denosumab, patent litigation, biosimilar, settlement, launch date